NASDAQ:EQRXW EQRx (EQRXW) Stock Price, News & Analysis → Biggest hedge fund manager has huge warning for U.S. dollar (From Stansberry Research) (Ad) Free EQRXW Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.05▼$0.0550-Day Range$0.04▼$0.0752-Week Range$0.04▼$1.12VolumeN/AAverage Volume14,363 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get EQRx alerts: Email Address Ad Stansberry ResearchBiggest hedge fund manager has huge warning for U.S. dollarPrescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money."Get the details before it's taken offline. About EQRx Stock (NASDAQ:EQRXW)Read More Ad Stansberry ResearchBiggest hedge fund manager has huge warning for U.S. dollarPrescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money."Get the details before it's taken offline. EQRXW Stock News HeadlinesApril 20, 2024 | seekingalpha.comBFYW Better For You Wellness, Inc.March 27, 2024 | finance.yahoo.comOne Biosciences Welcomes Dr. Scott Braunstein and Dr. Vincent Miller to its Board of DirectorsMay 10, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”February 27, 2024 | seekingalpha.comAbsci: Differentiated Antibody Discovery PlayFebruary 21, 2024 | msn.comAbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call TranscriptOctober 5, 2023 | benzinga.comEQRX Investors: Contact Robbins LLP for Information About our Investigation of EQRx, Inc.September 30, 2023 | seekingalpha.comEQRXW EQRx, Inc. WT EXP 121726September 25, 2023 | seekingalpha.comRevolution Medicines' Strategic Edge In RAS-Driven OncologyMay 10, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”August 11, 2023 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQRX, WMC, EMANAugust 8, 2023 | technews.tmcnet.comRevolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate ProgressAugust 3, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether EQRx, Inc. has obtained a Fair Price in its transaction with Revolution MedicinesAugust 3, 2023 | marketwatch.comEQRx Shares Rally 20% Premarket on Deal to Be Bought by Revolution MedicinesJuly 31, 2023 | benzinga.comBoundless Bio Appoints Jami Rubin as Chief Financial OfficerMay 10, 2023 | msn.comGoldman Sachs Maintains EQRx (EQRX) Neutral RecommendationMay 9, 2023 | marketwatch.com8-K: EQRx, Inc.April 26, 2023 | benzinga.comEQRx, Inc. (EQRX) Stock Investigation: Robbins LLP Reminds Investors it is Investigating EQRX, Inc.See More Headlines Receive EQRXW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EQRx and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorProfessional, Scientific, and Technical Services Industry Research and Development in Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:EQRXW CUSIPN/A CIK1843762 WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key CompetitorsPear TherapeuticsNASDAQ:PEARWVenus AcquisitionNASDAQ:VENAWView All Competitors This page (NASDAQ:EQRXW) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsShocking: One AI startup's revenue could surge 4,735%Manward PressGold ManiaStansberry Research[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EQRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
